Skip to main content
FDA Shortage Check

Is Demerol (Meperidine Hydrochloride Injection) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Demerol: in shortage (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
DRUG
Demerol
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
May 30, 2025
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 6 presentations: 0 unavailable · 0 limited · 6 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Meperidine Hydrochloride Injection. 6 presentations from 2 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Hikma Pharmaceuticals USA, Inc.3 presentations · 3 available or not stated

Contact (FDA's listing): 800-631-2174

  • 100 mg/1 mL

    Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-6054-25Reverified

    Available

  • 25 mg/1 mL

    Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-6052-25Reverified

    Available

  • 50 mg/1 mL

    Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0641-6053-25Reverified

    Available

Hospira, Inc., a Pfizer Company3 presentations · 3 available or not stated

Contact (FDA's listing): 844-646-4398

  • 25 mg/1 mL

    Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30)

    NDC 0409-1176-30Reverified

    Available

  • 50 mg/1 mL

    Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30)

    NDC 0409-1178-30Reverified

    Available

  • 50 mg/1 mL

    Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30)

    NDC 0409-1181-30Reverified

    Available

What the manufacturers told FDA

No recovery estimate posted by the makers.

More on FDA ↗ (opens in a new tab)

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Demerol in shortage?
Yes. As of Oct 24, 2026, FDA lists Meperidine Hydrochloride Injection as currently in shortage: 6 presentations, 0 unavailable and 0 limited.
When will the Demerol shortage end?
FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Demerol?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.